Sponsor

The University of Texas at Dallas

Clinical research sponsor

Published trials20
Recruiting shown3
Roles2
SourceClinicalTrials.gov

Clinical trials

20 shown
Treatment of Cognitive and Sensorimotor Deficits in Parkinson's Disease With High Definition Transcranial Direct Current StimulationNCT07534397 · lead sponsor · 2026-09-15
RECRUITING
Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current StimulationNCT05958381 · lead sponsor · 2023-10-18
RECRUITING
Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MSNCT06334094 · lead sponsor · 2024-06-01
WITHDRAWN
Breaking Through the Brain Fog: An Online Research StudyNCT05444231 · lead sponsor · 2023-08-23
COMPLETED
The Efficacy of Neural Stimulation in Individuals With SchizophreniaNCT05746494 · lead sponsor · 2022-11-21
COMPLETED
Impact of Challenging Engagement on Cognition in Older AdultsNCT03962439 · lead sponsor · 2019-06-01
TERMINATED
Improving Visual Attention in SchizophreniaNCT03880227 · lead sponsor · 2019-03-25
COMPLETED
Brain Energy Metabolism and Sleep in AdultsNCT03929302 · lead sponsor · 2018-11-30
TERMINATED
Stimulating the Brain to Improve Self-AwarenessNCT03370341 · lead sponsor · 2017-12-01
COMPLETED
Social Cognition Assessment in Young AdultsNCT02922400 · lead sponsor · 2006-11-01
COMPLETED
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective AccuracyNCT07098169 · collaborator · 2025-09-01
RECRUITING
Pregnenolone Treatment for Alcohol Use Disorder and Major Depressive DisorderNCT07734701 · collaborator · 2026-10-01
NOT_YET_RECRUITING
Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1NCT07254650 · collaborator · 2026-10-01
NOT_YET_RECRUITING
Pregnenolone for Cannabis Use Disorder and DepressionNCT07685964 · collaborator · 2026-09-01
NOT_YET_RECRUITING
Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderSNCT06426134 · collaborator · 2024-12-01
COMPLETED
Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.NCT06395662 · collaborator · 2024-04-15
COMPLETED
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic DisordersNCT05899348 · collaborator · 2023-10-01
COMPLETED
Assessment of Cancer Related Brain Fog Using the Test of Strategic LearningNCT05519774 · collaborator · 2022-08-01
COMPLETED
Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)NCT02843529 · collaborator · 2016-10-17
COMPLETED
Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-managementNCT02820038 · collaborator · 2016-09-01
COMPLETED

Sponsor roles

collaborator10
lead sponsor10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.